Regional Analysis

Global Pyrazinamide Market: Regional Analysis

On the basis of region, the global pyrazinamide market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant growth in the global pyrazinamide market, owing to increasing number of TB patient across the U.S. and Canada respectively. For instance, in 2019, according to data of the Centers for Disease Control and Prevention states that, around 8,916 number of TB cases were reported in the U.S. Similarly, in 2017, according to the Canada government data, there were around 1,796 number of TB cases reported in Canada, when compared with around 1,750 number of TB cases in 2016, indicates a 2.6% increase.

Additionally, in Europe, growth of the pyrazinamide market is attributed to high number of TB patients. For instance, according to European Centre for Disease Prevention and Control data around 55,337 TB cases were reported in year 2017, which was around rate of 10.7 per 100,000 population.

Fig.2. Global Pyrazinamide Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa